T2 Biosystems, Inc. (NASDAQ:TTOO – Get Free Report)’s stock price crossed above its fifty day moving average during trading on Wednesday. The stock has a fifty day moving average of $0.00 and traded as high as $0.0007. T2 Biosystems shares last traded at $0.0007, with a volume of 949 shares traded.
T2 Biosystems Stock Performance
The stock has a market capitalization of $14,730.10, a PE ratio of -0.00 and a beta of 8.13.
T2 Biosystems Company Profile
T2 Biosystems, Inc is a medical technology company that develops diagnostic products for the rapid detection of sepsis-causing pathogens and antimicrobial resistance. The company’s tests are designed to identify infections directly from blood samples, helping healthcare professionals make treatment decisions more quickly than traditional culture-based methods.
The company’s product portfolio is built around the T2Dx Instrument, an automated diagnostic platform that uses T2 Magnetic Resonance technology.
Further Reading
- Five stocks we like better than T2 Biosystems
- Bank of America Stock Sell-Off Looks Like a Buying Opportunity
- AST SpaceMobile Is Down 67%—Could SpaceX’s Mobile Push Deepen the Selloff?
- GlobalFoundries’ $21 Billion Deal Could Change the Economics of Chipmaking
- Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
